Catalyst Wire Dossier Catalyst Wire Dossier

Quixidar

fondaparinux sodium · Glaxo Group Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quixidar, covering 2008-05-16 to 2008-05-16. Get the full timeline:

Most recent: EMA Withdrawn: Quixidar (fondaparinux sodium) — Glaxo Group Ltd.

See pricing